GSK-3β Inhibition Attenuates CLP-Induced Liver Injury by Reducing Inflammation and Hepatic Cell Apoptosis

Figure 2

GSK-3β inhibition attenuates the inflammatory cytokine production following CLP. (a) GSK-3β inhibition altered mRNA expression of TNF-α, IL-6, IL-1β, and IL-10 in the liver of septic mice. (b) Serum TNF-α and IL-6 levels were assessed by ELISA. Data are shown as mean ± SD. per group. , ^# compared with vehicle-treated group.

(a)

(b)